<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">When considering adding convalescent plasma to the current armamentarium in the fight against COVID-19 infection, the pros and cons must be weighed. The pros would include possible clinical efficacy, immediate availability from a large donor pool, relative ease of procuring plasma through current approved methods, and potential cost advantages over some of the more experimental antivirals [
 <xref rid="bb0250" ref-type="bibr">50</xref>]. Additionally, convalescent plasma may also offer prophylactic benefits, which could keep our healthcare workers on the frontlines healthy as well as prevent self-quarantine after exposure, which risks decreasing an already overstretched workforce [
 <xref rid="bb0035" ref-type="bibr">7</xref>]. Clinically, some investigators have attempted to assess the prophylactic potential of convalescent plasma [
 <xref rid="bb0255" ref-type="bibr">51</xref>], but much more work is needed prior to drawing definitive conclusions.
</p>
